协和医学杂志
協和醫學雜誌
협화의학잡지
MEDICAL JOURNAL OF PEKING UNION MEDICAL COLLEGE HOSPITAL
2014年
4期
389-392
,共4页
简珊%王薇%魏珉%邱正庆
簡珊%王薇%魏珉%邱正慶
간산%왕미%위민%구정경
糖原累积症%肾上腺素刺激试验%基因诊断
糖原纍積癥%腎上腺素刺激試驗%基因診斷
당원루적증%신상선소자격시험%기인진단
glycogen storage disease%epinephrine stimulation test%gene diagnosis
目的:探讨肾上腺素刺激试验在糖原累积症( glycogen storage disease, GSD)Ⅰ型、Ⅲ型分型中的诊断价值。方法回顾性分析北京协和医院1991年3月至2012年2月收治的经基因确诊的GSDⅠ型及Ⅲ型患者的临床资料,所有患者均完成空腹及餐后肾上腺素刺激试验。以基因诊断结果为金标准,分析空腹及餐后肾上腺素刺激试验对GSD Ⅰ型及Ⅲ型分型的诊断价值。结果144例GSD患者中,男88例,女56例,平均年龄(5.77±4.58)岁;Ⅰa型68例,Ⅰb型20例,Ⅲ型56例。144例患者空腹刺激试验血糖均未明显增高。餐后刺激试验血糖明显升高44例,其中Ⅰ型8例,Ⅲ型36例,两组有效应患者的比例差异有统计学意义(P<0.01)。餐后肾上腺素刺激试验诊断GSDⅠ型的敏感度和特异度分别为90.9%和64.3%;诊断Ⅲ型的敏感度和特异度分别为64.3%和90.9%。年龄≤2.5岁较>2.5岁患者餐后刺激试验有效应者的比例差异有统计学意义(P<0.05)。年龄越大,肾上腺素刺激试验诊断敏感度和特异度越高。肾上腺素刺激试验诊断年龄>2.5岁的Ⅰ型患者的敏感度和特异度分别为95.4%和77.1%,诊断年龄>2.5岁的Ⅲ型患者的敏感度和特异度分别为77.1%和95.4%。结论肾上腺素刺激试验对 GSD Ⅰ型和Ⅲ型的临床分型仍具有一定意义,尤其2.5岁以上的GSD患者结果可靠性更高。
目的:探討腎上腺素刺激試驗在糖原纍積癥( glycogen storage disease, GSD)Ⅰ型、Ⅲ型分型中的診斷價值。方法迴顧性分析北京協和醫院1991年3月至2012年2月收治的經基因確診的GSDⅠ型及Ⅲ型患者的臨床資料,所有患者均完成空腹及餐後腎上腺素刺激試驗。以基因診斷結果為金標準,分析空腹及餐後腎上腺素刺激試驗對GSD Ⅰ型及Ⅲ型分型的診斷價值。結果144例GSD患者中,男88例,女56例,平均年齡(5.77±4.58)歲;Ⅰa型68例,Ⅰb型20例,Ⅲ型56例。144例患者空腹刺激試驗血糖均未明顯增高。餐後刺激試驗血糖明顯升高44例,其中Ⅰ型8例,Ⅲ型36例,兩組有效應患者的比例差異有統計學意義(P<0.01)。餐後腎上腺素刺激試驗診斷GSDⅠ型的敏感度和特異度分彆為90.9%和64.3%;診斷Ⅲ型的敏感度和特異度分彆為64.3%和90.9%。年齡≤2.5歲較>2.5歲患者餐後刺激試驗有效應者的比例差異有統計學意義(P<0.05)。年齡越大,腎上腺素刺激試驗診斷敏感度和特異度越高。腎上腺素刺激試驗診斷年齡>2.5歲的Ⅰ型患者的敏感度和特異度分彆為95.4%和77.1%,診斷年齡>2.5歲的Ⅲ型患者的敏感度和特異度分彆為77.1%和95.4%。結論腎上腺素刺激試驗對 GSD Ⅰ型和Ⅲ型的臨床分型仍具有一定意義,尤其2.5歲以上的GSD患者結果可靠性更高。
목적:탐토신상선소자격시험재당원루적증( glycogen storage disease, GSD)Ⅰ형、Ⅲ형분형중적진단개치。방법회고성분석북경협화의원1991년3월지2012년2월수치적경기인학진적GSDⅠ형급Ⅲ형환자적림상자료,소유환자균완성공복급찬후신상선소자격시험。이기인진단결과위금표준,분석공복급찬후신상선소자격시험대GSD Ⅰ형급Ⅲ형분형적진단개치。결과144례GSD환자중,남88례,녀56례,평균년령(5.77±4.58)세;Ⅰa형68례,Ⅰb형20례,Ⅲ형56례。144례환자공복자격시험혈당균미명현증고。찬후자격시험혈당명현승고44례,기중Ⅰ형8례,Ⅲ형36례,량조유효응환자적비례차이유통계학의의(P<0.01)。찬후신상선소자격시험진단GSDⅠ형적민감도화특이도분별위90.9%화64.3%;진단Ⅲ형적민감도화특이도분별위64.3%화90.9%。년령≤2.5세교>2.5세환자찬후자격시험유효응자적비례차이유통계학의의(P<0.05)。년령월대,신상선소자격시험진단민감도화특이도월고。신상선소자격시험진단년령>2.5세적Ⅰ형환자적민감도화특이도분별위95.4%화77.1%,진단년령>2.5세적Ⅲ형환자적민감도화특이도분별위77.1%화95.4%。결론신상선소자격시험대 GSD Ⅰ형화Ⅲ형적림상분형잉구유일정의의,우기2.5세이상적GSD환자결과가고성경고。
Objective To analyze the value of epinephrine stimulation test in distinguishing type Ⅰand type Ⅲglycogen storage diseases ( GSD) .Methods The clinical data of genetically diagnosed type Ⅰand ⅢGSD patients from March 1991 to February 2012 in Peking Union Medical College Hospital were retrospectively analyzed .All the patients finished fasting and postprandial epinephrine stimulation test .The diagnostic value of fasting and postprandial epinephrine stimulation test was evaluated against gene diagnosis as the gold standard . Results Totally, 144 GSD patients (88 males and 56 females) with an average age of (5.77 ±4.58 ) years were included .There were 68 cases of GSD type Ⅰa, 20 cases of GSD type Ⅰb, and 56 cases of GSD type Ⅲ. Fasting epinephrine stimulation test showed no significant increase in blood glucose level in all the 144 patients, while postprandial epinephrine stimulation test exhibited that blood glucose level significantly increased in 44 ca-ses , including 8 cases of type Ⅰand 36 cases of type Ⅲ, with significant difference in the percentage of patients effective to the test between the two types ( P<0.01 ) .The sensitivity and specificity of postprandial epinephrine stimulation test in diagnosing GSD type Ⅰwere 90.9%and 64.3%, respectively , and those in diagnosing GSD type Ⅲwere 64.3%and 90.9%, respectively .The sensitivity and specificity in patients ≤2.5 years old were significantly lower than those in patients >2.5 years old (P<0.01).In patients >2.5 years, the sensitivity and specificity of epinephrine stimulation test were 95.4%and 77.1%in GSD Ⅰ, and 77.1%and 95.4%in GSD type Ⅲ.Conclusion Epinephrine stimulation test still can be helpful in distinguishing GSD type Ⅰ and GSD type Ⅲ, especially liable in patients >2.5 years old .